GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Standard Chemical & Pharmaceutical Co Ltd (TPE:1720) » Definitions » Total Assets

Standard Chemical & Pharmaceutical Co (TPE:1720) Total Assets : NT$11,572 Mil (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Standard Chemical & Pharmaceutical Co Total Assets?

Standard Chemical & Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was NT$11,572 Mil.

Warning Sign:

If a company builds assets at 11.2% a year, faster than its revenue growth rate of 8.8% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Standard Chemical & Pharmaceutical Co's average Total Assets Growth Rate was 12.70% per year. During the past 3 years, the average Total Assets Growth Rate was 16.90% per year. During the past 5 years, the average Total Assets Growth Rate was 11.20% per year. During the past 10 years, the average Total Assets Growth Rate was 5.90% per year.

During the past 13 years, Standard Chemical & Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 16.90%. The lowest was 0.90%. And the median was 6.10%.

Total Assets is connected with ROA %. Standard Chemical & Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 was 8.98%. Total Assets is also linked to Revenue through Asset Turnover. Standard Chemical & Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.14.


Standard Chemical & Pharmaceutical Co Total Assets Historical Data

The historical data trend for Standard Chemical & Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard Chemical & Pharmaceutical Co Total Assets Chart

Standard Chemical & Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,439.11 6,928.00 7,049.45 10,095.04 10,968.26

Standard Chemical & Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,968.26 10,999.66 11,215.12 10,953.52 11,571.62

Standard Chemical & Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Standard Chemical & Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets=Total Equity (A: Dec. 2022 )+Total Liabilities (A: Dec. 2022 )
=7435.601+3532.658
=10,968

Standard Chemical & Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=8047.785+3523.836
=11,572

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Standard Chemical & Pharmaceutical Co  (TPE:1720) Total Assets Explanation

Total Assets is connected with ROA %.

Standard Chemical & Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1010.816/( (10953.524+11571.621)/ 2 )
=1010.816/11262.5725
=8.98 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Standard Chemical & Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1613.535/( (10953.524+11571.621)/ 2 )
=1613.535/11262.5725
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Standard Chemical & Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Standard Chemical & Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Standard Chemical & Pharmaceutical Co (TPE:1720) Business Description

Traded in Other Exchanges
N/A
Address
No. 154, Kaiyuan Road, Xinying District, Tainan, TWN, 73055
Standard Chemical & Pharmaceutical Co Ltd is a pharmaceutical company. Along with its subsidiaries, the firm is engaged in the pharmaceutical development, manufacturing, and sales of Active Pharmaceuticals Ingredients (API), health supplements, medical equipment, neoangelac plus milk powder, and adult supplements. It offers pharmaceutical products in healthcare segments including the circulatory system, digestive system, metabolism, anti-microbial, membrane drugs, and respiratory system. The company generates a majority of its revenue from Taiwan.

Standard Chemical & Pharmaceutical Co (TPE:1720) Headlines

No Headlines